contexts to the Australian healthcare environment Prof. Nilmini - PowerPoint PPT Presentation

Translating developed technology oncology platforms from other healthcare contexts to the Australian healthcare environment Prof. Nilmini Wickramasinghe A/Prof. Paul Cooper Dr Muhammad Nadeem Shuakat Ms Cassandra Schultz Deakin University CRICOS Provider Code: 00113B

Agenda • Background • What is an Oncology Platform • Benefits sought • The study • The Australian/Victorian context • Socio-technical lens • Initial findings • Next steps 2 Oncology Platform Prof. Nilmini Wickramasinghe , A/Prof. Paul Cooper et al. Deakin University CRICOS Provider Code: 00113B DEAKIN MEDICAL SCHOOL

Incidence of cancer continues to impact the health system AIHW: In 2013-14 there were around 936,000 cancer-related hospitalisations - an increase of 44% from 2001 – 02, when there were around 649,000 cancer-related hospitalisations. Over the same period, the age- standardised cancer-related hospitalisation rate increased by 8.9% from 337 per 10,000 population to 367 per 10,000. The top five most common reasons for cancer-related hospitalisations accounted for 96% of all hospitalisations where the principal diagnosis was a cancer-related treatment or service. With aging population, cancer has stretched developed countries’ health care systems in terms of financial, manpower and staff required to look after and manage treatment for cancer patients. 3 Oncology Platform Prof. Nilmini Wickramasinghe , A/Prof. Paul Cooper et al. Deakin University CRICOS Provider Code: 00113B DEAKIN MEDICAL SCHOOL

How an OIS can help • Managing treatment plans, dose planning, image based decision. • Improving accuracy of treatment • Accessing data from multiple sites, reducing paper based data, online image reviewing in 2D and 3D, transferring data to external sites. • Giving access to patient for making appointments, getting knowledge about before and after treatments, joining support groups • Reduction in cost by eliminating clerical staff, reducing paper/film usage, delays in results transfer and reduces patient waiting time • Giving patients access to their treatment summary, disease specific knowledge related to side,-late effects, health monitoring and support services along with managing appointments and print or fill questionnaires or forms before appointment. 4 Oncology Platform Prof. Nilmini Wickramasinghe , A/Prof. Paul Cooper et al. Deakin University CRICOS Provider Code: 00113B DEAKIN MEDICAL SCHOOL

Benefits sought for Oncology Platforms Improved quality of care eg by connecting More rapid diagnosis electronic records to and treatment eg enable sharing of linked systems clinical data together with genomic data, Improved integrated registry data and patient care e.g. through self-reported data on a shared records and large scale. collaborative working tools More appropriate and tailored therapeutic protocol to be developed for each Improved efficiency patient eg through reduced clerical staff Lower costs e.g. Monitoring the progress through dashboards of patients in their which give insights treatment, to enable into expensive, more informed and possibly avoidable improved decisions treatments about patient care 5 Oncology Platform Prof. Nilmini Wickramasinghe , A/Prof. Paul Cooper et al. Deakin University CRICOS Provider Code: 00113B DEAKIN MEDICAL SCHOOL

Major functions of OIS • Integration of radiation oncology, particle therapy and medical oncology patient data in a single database • Accessibility of patient data for multi-disciplinary teams from multiple locations with second by second data update • Seamless connectivity to any linear accelerator & treatment planning system • Evaluation of diagnosis-specific data to compare acute responses to treatment and long-term clinical outcomes • Development of disease-specific clinical protocols to facilitate a standard, consistent quality of care • Monitoring radiation dose and reviewing treatment images to determine if plan changes are required • Calculating medication doses for entire treatment based on pre-defined dosing rules specific for each pathway 6 Oncology Platform Prof. Nilmini Wickramasinghe , A/Prof. Paul Cooper et al. Deakin University CRICOS Provider Code: 00113B DEAKIN MEDICAL SCHOOL

What our study is aiming to examine Phase One of the project reports on a systematic literature review of three international platforms that have the potential to deliver high-value patient centred care to cancer patients in an Australian context and examines a range of factors including functionality, usability, and translation of such platforms to the Australian healthcare context. 7 Oncology Platform Prof. Nilmini Wickramasinghe , A/Prof. Paul Cooper et al. Deakin University CRICOS Provider Code: 00113B DEAKIN MEDICAL SCHOOL

The Australian/Victorian context - strategic intents of Digital Health (DHHS Vic) Source: DHHS (Vic) 8 Oncology Platform Prof. Nilmini Wickramasinghe , A/Prof. Paul Cooper et al. Deakin University CRICOS Provider Code: 00113B DEAKIN MEDICAL SCHOOL

The Victorian Digital Health Landscape (DHHS Vic) 9 Oncology Platform Prof. Nilmini Wickramasinghe , A/Prof. Paul Cooper et al. Deakin University CRICOS Provider Code: 00113B DEAKIN MEDICAL SCHOOL

Victorian Digital Health Guiding Principles • Clinical engagement – clinicians must be actively involved in championing health technologies, realising expected benefits and efficiencies. • Information and analytics – information should be available across the full, unified continuum of carers/researchers to enable demand management and personalised healthcare. • Adherence to agreed standards and interoperability – explicit adoption of greed standards facilitates information flow and advances interoperability and quality of technology solutions. • Robust and transparent governance • Value-for-money and Business-driven – decision making should be made by and for business reasons rather than be driven by the technology. 10 Oncology Platform Prof. Nilmini Wickramasinghe , A/Prof. Paul Cooper et al. Deakin University CRICOS Provider Code: 00113B DEAKIN MEDICAL SCHOOL

National Strategic Principles • Putting users at the centre • Ensuring privacy and security • Fostering agile collaboration • Driving a culture of safety and quality • Improving equity of access • Leveraging existing assets and capabilities • Judicious use of taxpayer money - ensure that investments are assessed on the basis of delivering the best health and care outcomes for all Australians. 11 Oncology Platform Prof. Nilmini Wickramasinghe , A/Prof. Paul Cooper et al. Deakin University CRICOS Provider Code: 00113B DEAKIN MEDICAL SCHOOL

Using Activity Theory to inform our comparison (the LENS): Enables the understanding of interactions between human activities and various work practices (Leont'ev) 12 Oncology Platform Prof. Nilmini Wickramasinghe , A/Prof. Paul Cooper et al. Deakin University CRICOS Provider Code: 00113B DEAKIN MEDICAL SCHOOL

Activity Theory Elements Element Area Subject Oncologists & Nurses Object Cancer patients & Family Tool Cancer Platform 13 Oncology Platform Prof. Nilmini Wickramasinghe , A/Prof. Paul Cooper et al. Deakin University CRICOS Provider Code: 00113B DEAKIN MEDICAL SCHOOL

Our Overall Comparative Lens Adherence to agreed Clinician led and patient-centric : enabling Internationa and Australian high levels of clinical engagement, while standards and interoperability being patient-centric. Putting users at the & leveraging existing assets and centre & fostering agile collaboration capabilities Information and analytics – information needs to be available across the full, unified continuum of care and be available for research to enable demand management and personalised healthcare Robust privacy and security Value-for-money – the selected digital technology solution must provide Safety and Quality value for money 14 Oncology Platform Prof. Nilmini Wickramasinghe , A/Prof. Paul Cooper et al. Deakin University CRICOS Provider Code: 00113B DEAKIN MEDICAL SCHOOL